Cargando…

Progesterone reduces cell survival in primary cultures of endometrioid ovarian cancer

BACKGROUND: Ovarian cancer is the most lethal of all gynecologic malignancies. The relationship between sexual steroids receptors and ovarian cancer progression has been largely evaluated. The presence of progesterone receptors has been associated with an increase of a disease-free period and overal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedernera, Enrique, Gómora, María J., Morales-Vásquez, Flavia, Pérez-Montiel, Delia, Mendez, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367846/ https://www.ncbi.nlm.nih.gov/pubmed/30736825 http://dx.doi.org/10.1186/s13048-019-0486-4

Ejemplares similares

Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors
por: Calvillo-Robledo, Argelia, et al.
Publicado: (2021)

Sexual steroid hormone receptors profiles of ovarian carcinoma in Mexican women
por: Gómora, María J, et al.
Publicado: (2018)

Estrogen and androgen receptor expression in surface epithelium and inclusion cyst in the ovary of premenopausal and postmenopausal women
por: Mendez, Carmen, et al.
Publicado: (2013)

High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma
por: Morales-Vásquez, Flavia, et al.
Publicado: (2016)

Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors
por: Morales-Vásquez, Flavia, et al.
Publicado: (2020)

Androgen receptor is expressed in mouse cardiomyocytes at prenatal and early postnatal developmental stages
por: Pedernera, Enrique, et al.
Publicado: (2017)

Primary ovarian endometrioid stromal sarcoma presenting with reno-ureteral colic
por: Moral, Ana Isabel Bueno, et al.
Publicado: (2022)

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis
por: Pearce, C L, et al.
Publicado: (2008)

The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer
por: Erkılınç, Gamze, et al.
Publicado: (2023)

Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis
por: Pecorino, Basilio, et al.
Publicado: (2022)

Diagnostic performance of intraoperative assessment in grade 2 endometrioid endometrial carcinoma
por: Bandala-Jacques, Antonio, et al.
Publicado: (2020)

Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications
por: Rambau, Peter, et al.
Publicado: (2017)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

Genomic mutation features identify distinct BRCA-associated mutation characteristics in endometrioid carcinoma and endometrioid ovarian carcinoma
por: Cao, Canhui, et al.
Publicado: (2021)

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
por: Yoneoka, Yutaka, et al.
Publicado: (2018)

Testosterone-Secreting Endometrioid Ovarian Carcinoma Presenting With Hyperandrogenism
por: Rajamani, Krishnakumar, et al.
Publicado: (2022)

Synchronous occurrence of primary right ovarian endometrioid adenocarcinoma and primary left ovarian clear cell adenocarcinoma: A case report
por: Zhao, Ling-jun, et al.
Publicado: (2018)

Comparative study of endometrioid borderline ovarian tumor with and without endometriosis
por: Zhang, Wen, et al.
Publicado: (2018)

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
por: Hollis, Robert L., et al.
Publicado: (2020)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

Ovarian Carcinoid Misinterpreted as Endometrioid Adenocarcinoma in Mature Cystic Teratoma
por: Tewari, Prerna, et al.
Publicado: (2020)

Long-term survival of endometrioid endometrial cancer patients
por: Gottwald, Leszek, et al.
Publicado: (2010)

The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification
por: Guan, Jun, et al.
Publicado: (2018)

A case of ovarian yolk sac tumor associated with endometrioid adenocarcinoma
por: Koi, Chiho, et al.
Publicado: (2014)

Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas
por: Agostini, Antonio, et al.
Publicado: (2018)

Prognostic analysis for Chinese patients with stage I ovarian endometrioid carcinoma
por: Zhao, Yu, et al.
Publicado: (2017)

Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors
por: Crean-Tate, Katie K., et al.
Publicado: (2021)

Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification
por: Hollis, Robert L., et al.
Publicado: (2021)

90 Years of progesterone: Ninety years of progesterone: the ‘other’ ovarian hormone
por: Ali, Simak, et al.
Publicado: (2020)

Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma
por: Torng, Pao-Ling, et al.
Publicado: (2009)

MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
por: Li, Hai Ming, et al.
Publicado: (2015)

Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours
por: Jia, Shuang-zheng, et al.
Publicado: (2018)

A case of ovarian endometrioid adenocarcinoma with yolk sac differentiation and Lynch syndrome
por: Sookram, Janhvi, et al.
Publicado: (2019)

Four cases of endometrioid borderline ovarian tumour: case reports and literature review
por: Nakagawa, Eriko, et al.
Publicado: (2017)

A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer
por: Chen, Shuangfeng, et al.
Publicado: (2021)

Mast Cell Tryptase and Carboxypeptidase A3 in the Formation of Ovarian Endometrioid Cysts
por: Atiakshin, Dmitri, et al.
Publicado: (2023)

Estrogen, Progesterone and Epithelial Ovarian Cancer
por: Ho, Shuk-Mei
Publicado: (2003)

Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma
por: Xiang, Michael, et al.
Publicado: (2019)

Survival of women with ovarian carcinomas and borderline tumors is not affected by estrogen and progesterone receptor status
por: Sallum, Luis Felipe, et al.
Publicado: (2013)

Endometrioid Paraovarian Borderline Cystic Tumor in an Infant with Proteus Syndrome
por: Vasquez, Liliana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4204vjp9jiqnb93hrqms398a3o